secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001140361-25-001687
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galectin Therapeutics furnishes annual meeting presentation transcript; no material new details disclosed
--------------------------------------------------------------------------------

- Filed a transcript of a presentation made after the January 23, 2025 Annual Meeting of Stockholders under Item 7.01.
- The provided transcript excerpt contains only an opening thank-you and a forward-looking statement disclaimer; substantive content is absent from the filing.
- No financial results, pipeline updates, or guidance changes are reported in the furnished exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036125001687/0001140361-25-001687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036125001687/ef20042040_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-001687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer